KLIFO
Thomas Matthiesen is an experienced project director with a diverse background in project management within the pharmaceutical and biotech sectors. Currently serving as Project Director at KLIFO A/S since 2015, Thomas previously held significant roles at Novo Nordisk, Takeda Pharma A/S, and Nycomed, focusing on leading teams and managing projects across various therapeutic areas, particularly in osteoporosis and tissue management. Thomas's expertise is supported by a Master of Science in Chemistry and Cell Biology from the University of Southern Denmark and further education in medical product innovation and leadership development. The career trajectory includes roles at the Danish Meat Association and teaching positions, showcasing a broad skill set developed over several decades in various industries.
This person is not in any teams
KLIFO
KLIFO is an integrated North-European drug development consultancy with significant experience in partnering with pharmaceutical and biotech companies. We enable our partners to maximise opportunity, mitigate risks, drive innovation and achieve efficient project advancement. We offer end to end solutions across all drug development areas, including strategic project management, regulatory affairs, clinical development, clinical trial supply, quality assurance (QA), Chemistry Manufacturing and Controls (CMC) development, non-clinical development and pharmacovigilance in relation to the development of pharmaceutical products. We provide strategic advice as well as operational support in all these areas, and we partner with clients on portfolio strategies, project development strategies and project execution. KLIFO has offices in Denmark, Sweden, Germany and The Netherlands and employs more than 150 highly skilled employees.